Microba Life Sciences Ltd

Microba Investor Hub - Webinars

Microba Investor Hub

Microba Investor Hub - Corporate Governance

Microba Investor Hub - Shareholder Information

Corporate

Microba Investor Hub - News & Media

Microba Investor Hub - Announcements

DM Sans

Microba Life Sciences Ltd (ASX:MAP) CEO Dr Luke Reid speaks to Proactive's Thomas Warner about the company's work in developing gut microbiome testing services and associated therapeutics. Reid says that microbiome testing will become "routine" during the coming years and that Microba is well-placed to take advantage of a potentially huge emerging market.

Proactive Investors interview with Microba CEO (ASX:MAP)